
Ep. 104 - Biotech Shows Support for Ukraine, Plus Latest Intellia Data
BioCentury This Week
00:00
Biotexs
There are a couple other new modalities on the market. It's more effective. And crisper cas onis potentially a one time treatment, which is the biggest difference for patients who would have to be treated with an s i r an a or an r an a i, relatively frequently every couple months. Here's hoping it's good for the sector. A, it's been a pretty dreary past 52 weeks. Any thoughts on that? Loren, well, their share price has risen about 20 % over the last five days leading up to this announcement. So investors were optimistic about the data. Of course, crisper and editas are also stocks to watch.
Transcript
Play full episode